title: Crimean-Congo hemorrhagic fever in Turkey: Current status and future challenges.
abstract: Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral disease of humans that affects a wide geographic area of Africa and Eurasia, including Turkey, Iran, Pakistan, Afghanistan and Russia. Since the first detection of CCHF cases in Turkey in 2002, more than 9700 patients have been reported, with an overall mortality rate just under 5%. This article assesses the present epidemiological situation of CCHF in Turkey, with an updated literature review, describes national practices and summarizes lessons learned in preparation for future outbreaks.
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Samsun, Turkey. Electronic address: hakanomu@yahoo.com.
authors.forename: Hakan
authors.initials: H
authors.lastname: Leblebicioglu
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey. Electronic address: rozaras@yahoo.com.
authors.forename: Resat
authors.initials: R
authors.lastname: Ozaras
authors.affiliation: Republic of Turkey Ministry of Health, Ankara, Turkey. Electronic address: hsn.irmak@gmail.com.
authors.forename: Hasan
authors.initials: H
authors.lastname: Irmak
authors.affiliation: Department of Infectious Diseases and Clinical Microbiology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey. Electronic address: isencanibu@yahoo.com.
authors.forename: Irfan
authors.initials: I
authors.lastname: Sencan
mesh_terms: D000818:Animals; D004196:Disease Outbreaks; D003225:Hemorrhagic Fever Virus, Crimean-Congo / Q000302:isolation & purification*; D006479:Hemorrhagic Fever, Crimean / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000628:therapy / Q000821:virology; D049674:History, 21st Century; D006801:Humans; D011379:Prognosis; D014421:Turkey / Q000453:epidemiology
keywords: Arbovirus; Crimean-Congo hemorrhagic fever; Epidemic preparedness; Ribavirin; Tick-borne disease; Turkey